Fuxiang Wang

7.9k total citations · 2 hit papers
29 papers, 2.3k citations indexed

About

Fuxiang Wang is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Fuxiang Wang has authored 29 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Fuxiang Wang's work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Fuxiang Wang is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Fuxiang Wang collaborates with scholars based in China, United States and Canada. Fuxiang Wang's co-authors include Jing Yuan, Zheng Zhang, Ido Amit, Yang Liu, Yanling Wen, Jinxiu Li, Lin Cheng, Xin Wang, Juanjuan Zhao and Mingfeng Liao and has published in prestigious journals such as Cell, Nature Medicine and Nature Communications.

In The Last Decade

Fuxiang Wang

28 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

2020 1.6k citations Mingfeng Liao, Yang Liu et al. Nature Medicine profile →
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020

2020 506 citations Xuejiao Liao, Jing Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuxiang Wang China	11	1.4k	534	528	471	283	29	2.3k
Zhang Qi China	19	1.0k 0.7×	289 0.5×	346 0.7×	605 1.3×	152 0.5×	82	2.3k
Haijun Deng China	16	1.8k 1.3×	226 0.4×	413 0.8×	564 1.2×	150 0.5×	61	2.8k
Waradon Sungnak United States	6	1.1k 0.8×	522 1.0×	501 0.9×	263 0.6×	198 0.7×	7	2.2k
Weiliang Tang China	12	1.1k 0.8×	337 0.6×	536 1.0×	262 0.6×	306 1.1×	33	2.4k
Yongxiang Yi China	20	1.7k 1.2×	250 0.5×	316 0.6×	579 1.2×	179 0.6×	49	2.8k
Marie‐Charlotte Brüggen Switzerland	23	1.3k 0.9×	944 1.8×	570 1.1×	420 0.9×	201 0.7×	62	3.5k
Lei Tu China	20	1.6k 1.2×	288 0.5×	863 1.6×	442 0.9×	322 1.1×	62	3.1k
Rasmus Møller United States	5	2.1k 1.5×	756 1.4×	814 1.5×	644 1.4×	148 0.5×	6	2.9k
Josephine L. Barnes United Kingdom	9	1.2k 0.8×	227 0.4×	500 0.9×	506 1.1×	293 1.0×	10	2.2k
Kohei Oishi United States	10	2.2k 1.5×	815 1.5×	813 1.5×	699 1.5×	154 0.5×	14	3.0k

Countries citing papers authored by Fuxiang Wang

Since Specialization

Citations

This map shows the geographic impact of Fuxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxiang Wang more than expected).

Fields of papers citing papers by Fuxiang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxiang Wang. The network helps show where Fuxiang Wang may publish in the future.

Co-authorship network of co-authors of Fuxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxiang Wang. A scholar is included among the top collaborators of Fuxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxiang Wang. Fuxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Zhen, Yang Yang, Fuxiang Wang, et al.. (2025). Thermally programmed one-pot CRISPR assay for on-site pandemic surveillance. Nature Communications. 16(1). 10286–10286.

Xu, Zhou-Geng, Yujie Liu, Long Wang, et al.. (2025). A unified cell atlas of vascular plants reveals cell-type foundational genes and accelerates gene discovery. Cell. 188(22). 6370–6390.e29. 2 indexed citations

Gong, Xiaohua, Ling Peng, Fuxiang Wang, et al.. (2024). Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants. Journal of Infection. 89(2). 106208–106208. 3 indexed citations

Wang, Fuxiang, Wen Xiao, Yimin Tang, et al.. (2023). Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial. The Lancet Regional Health - Western Pacific. 38. 100835–100835. 25 indexed citations

Qi, Furong, Gang Xu, Xuejiao Liao, et al.. (2021). ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers. Cell Discovery. 7(1). 56–56. 6 indexed citations

Zhang, Peiyan, Zhao Cai, Weibo Wu, et al.. (2020). The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report. BMC Infectious Diseases. 20(1). 12 indexed citations

Chen, Chuming, Haihui Wang, Zhichao Liang, et al.. (2020). Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China. The Innovation. 1(1). 100007–100007. 22 indexed citations

Liao, Mingfeng, Yang Liu, Jing Yuan, et al.. (2020). Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nature Medicine. 26(6). 842–844. 1562 indexed citations breakdown →

Zhao, Miaomiao, Baohua Liu, Tong Zheng, et al.. (2019). Factors associated with hostility among people living with HIV/AIDS in Northeast China: a cross-sectional study. BMC Public Health. 19(1). 1189–1189. 20 indexed citations

10.

Song, Bo, et al.. (2018). The relationship of social support, mental health, and health-related quality of life in human immunodeficiency virus-positive men who have sex with men. Medicine. 97(30). e11652–e11652. 25 indexed citations

11.

Wang, Jiaye, et al.. (2018). Identification of a New HIV-1 Circulating Recombinant Form CRF65_cpx Strain in Jilin, China. AIDS Research and Human Retroviruses. 34(8). 709–713. 5 indexed citations

12.

Mu, Xiaoqin, Binbin Liu, William Y. C. Huang, et al.. (2016). A rapid loop-mediated isothermal amplification (LAMP) method for detection of the macrolide–streptogramin type B resistance gene msrA in Staphylococcus aureus. Journal of Global Antimicrobial Resistance. 7. 53–58. 10 indexed citations

13.

Chen, Yanmin, Yin Bai, Xiaochen Guo, et al.. (2016). Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library. Biologicals. 44(4). 271–275. 2 indexed citations

14.

Chen, Xiaohong, et al.. (2016). PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.. PubMed. 8(10). 4354–4361. 10 indexed citations

15.

Bai, Yin, Yanmin Chen, Nan Zhang, et al.. (2015). Isolation of the neutralization ScFvs against HBV infection from the immunized population. Current Pharmaceutical Biotechnology. 16(10). 902–910. 1 indexed citations

16.

Li, Wenjing, Ting Liu, Qinghai Li, et al.. (2013). Subtype B Was the Dominant Strain Among HIV Type 1 Infections Except for the Population of Men Who Have Sex with Men in Harbin City, China. AIDS Research and Human Retroviruses. 29(9). 1260–1264. 9 indexed citations

17.

Li, Yi, et al.. (2013). The HIV/AIDS epidemic characteristics in a northeast province of China—Men who have sex with men have made a tremendous contribution to the growth of the HIV epidemic. Journal of Infection. 68(3). 273–280. 20 indexed citations

18.

Li, Hang, et al.. (2012). Analysis of Human Immunodeficiency Virus Type 1 Vif Gene Sequences Among Men Who Have Sex with Men in Heilongjiang Province of China. AIDS Research and Human Retroviruses. 29(5). 842–847. 1 indexed citations

19.

Wang, Fuxiang. (2011). A survey of the quality of life of people living with HIV/AIDS receiving and not receiving highly active antiretroviral treatment. Chinese Journal of AIDS & STD. 1 indexed citations

20.

Jiang, Xueyan, Hongzhou Lu, Yuexin Zhang, et al.. (2008). A Cross-Sectional Study of HIV and Tuberculosis Coinfection Cases in Mainland China. Southern Medical Journal. 101(9). 914–917. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact